Searchable abstracts of presentations at key conferences in endocrinology

ea0022oc2.2 | Thyroid | ECE2010

Systemic sodium iodide symporter (NIS) gene transfer in hepatocellular carcinoma using EGF-receptor targeted non-viral gene delivery vectors

Klutz Kathrin , Schaffert David , Rodl Wolfgang , Willhauck Michael J , Cengizeroglu Arzu , Wunderlich Nathalie , Gildehaus Franz Josef , Wagner Ernst , Goke Burkhard , Ogris Manfred , Spitzweg Christine

We have recently demonstrated induction of tumor-selective accumulation and therapeutic efficacy of radioiodine in neuroblastoma tumors after systemic non-viral polyplex-mediated sodium-iodide-symporter (NIS) gene delivery.In the current study, we evaluated the efficacy of novel synthetic nanoparticle vectors based on linear polyethylenimine (LPEI), shielded by polyethylene glycol (PEG), and coupled with the synthetic peptide GE11 as an epidermal growth ...

ea0016p755 | Thyroid | ECE2008

Image-guided radionuclide therapy of malignant melanoma following tumor-specific sodium iodide symporter (NIS) gene transfer

Willhauck Michael , Kessel Anne , Klutz Katrin , Samani Bibi Rana Sharif , Wunderlich Nathalie , Gildehaus Franz Josef , Zach Christian , Berking Carola , Vile Richard , Goke Burkhard , Spitzweg Christine

In its early stages, malignant melanoma can be cured by surgical resection, but once it has progressed to the metastatic stage it does not respond to current therapies. Therefore, the development of novel treatment strategies, such as gene therapy, is urgently needed. To investigate an alternative approach, we examined the feasibility of NIS-mediated radionuclide therapy (131I, 188Re) of malignant melanoma following human sodium iodide symporter (NIS) gen...